Friday, July 25, 2025 1:34:21 PM
Now here’s where NICE comes into the picture. NICE is like the registrar’s office. They don’t approve the degree. They don’t decide if the student passed. They’re just waiting for the final paperwork. When they say, “We haven’t received anything yet, the company isn’t ready,” that’s like the registrar saying, “The student hasn’t handed us the diploma packet yet.” That tells you the university already handed things off. The student is now finalizing the last details.
That’s what the NICE letter shows. MHRA’s role is likely complete. The ball is with NWBO. And that means we’re not in limbo, we’re in the final steps. Quiet isn’t failure. It’s process. It means the degree’s been earned, and now it’s just being printed.
Come on man, just stop.
There is a massive gap in the logic here and you know it (or maybe you don't, it's becoming apparent you may actually be this dumb).
You have given no evidence so support your claim that MHRA has internally approved.
In your analogy:
that’s like the registrar saying, “The student hasn’t handed us the diploma packet yet.” That tells you the university already handed things off. The student is now finalizing the last details.
NICE doesn't ask the MHRA if a product has been internally approved. They simply don't have the evidence submission from NWBO yet. Could be because NWBO is waiting on labeling, sure. Could also be because NWBO is in the middle of another RFI and doesn't want to submit EP until the approval is complete. Could be because they got referred to CHM for rejection and are appealing. All NICE knows is that they don't have the evidence submission.
Stop this irresponsible pumping.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
